BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is headed up in the market this morning, and for good reason. The company announced that its ORLADEYO product has been approved for commercialization in Japan. Here’s what’s happening: Skip to What You Want to Read BioCryst Pharmaceuticals Announces ORLADEYO Approval Management Commentary Why Investors Are Excited What Analysts Think … Read more
Adamis Pharmaceuticals Corp (NASDAQ: ADMP) is screaming for the top in the market this morning, after the company announced that its epinephrine injection product is now available to members of the Walgreens Prescription Savings Club. Here’s what’s going on: Skip to What You Want to Read SYMJEPI Is Now Available to Walgreens Prescription Savings Club … Read more
Celsion Corporation (NASDAQ: CLSN) is running for the top in the market this morning, climbing more than 80% in the premarket hours. The gains come after the company announced the termination of a share purchase agreement. Here’s what’s going on: Skip to What You Want to Read Celsion Announces the Termination of a Share Purchase … Read more
Vinco Ventures Inc (NASDAQ: BBIG) is screaming for the top in the market this morning, and for good reason. The company announced a merger that will establish a new streaming player. Here’s what’s going on: Skip to What You Want to Read Vinco Ventures Enters Agreement With Zash Global Media Why This Is a Big … Read more
Aptorum Group Ltd (NASDAQ: APM) is running for the top in the market this morning, and for good reason. The company announced that Health Canada has approved the company’s application to begin a Phase 1 study. Here’s what’s happening. Skip to What You Want to Read Aptorum Group Announces Phase 1 Study Approval Management Commentary … Read more
Gevo Inc (NASDAQ: GEVO) is having a rough day in the premarket hours this morning. After climbing more than 70% yesterday, the stock is down over 20% today. The declines seem to be the result of a registered direct offering through which the company expects to raise $350 million. While dilution is no fun, there’s … Read more
Caladrius Biosciences Inc (NASDAQ: CLBS) is screaming for the top in the market this morning. After a press release yesterday informed investors about the first patient treated in a Phase 2b trial, the stock popped slightly. However, that upward movement seems to have triggered a short squeeze that’s leading to dramatic gains today. Here’s what’s … Read more
Gevo Inc (NASDAQ: GEVO) is screaming for the top in the market this morning after announcing that it will participate in the Water Tower Research Fireside Chat Series. While that is exciting news, there’s far more exciting news in the future for the company. Here’s what’s going on: Skip to What You Want to Read … Read more
TransEnterix Inc (NYSEAMERICAN: TRXC) is screaming for the top in the market this morning, and for good reason. The company announced that it has received the CE Mark for the Intelligent Surgical UnitTM, also known as ISUTM. Here’s what’s happening: Skip to What You Want to Read TransEnterix Announces CE Mark Approval Management Commentary What … Read more
Zomedica Corp (NYSEAMERICAN: ZOM) is having an incredibly strong start to the trading session this morning, and for good reason. The CEO of the company, Robert Cohen, issued a letter to shareholders ahead of the launch of the TRUFORMA diagnostics platform. Here’s what’s going on: Skip to What You Want to Read Zomedica CEO Issues … Read more